{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:27:52Z","timestamp":1792196872627,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.rmed.2020.105904","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T21:58:37Z","timestamp":1582063117000},"page":"105904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The effect of doxofylline in asthma and COPD"],"prefix":"10.1016","volume":"164","author":[{"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2020.105904_bib1","author":"Global strategy for the diagnosis"},{"key":"10.1016\/j.rmed.2020.105904_bib2","author":"Global Initiative for Asthma"},{"key":"10.1016\/j.rmed.2020.105904_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rmed.2018.05.015","article-title":"Nationwide use of theophylline among adults-A 20-year Danish drug utilisation study","volume":"140","author":"Henriksen","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2020.105904_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1164\/rccm.201302-0388PP","volume":"188","author":"Barnes","year":"2013","journal-title":"Theophylline. Am J Respir Crit Care Med."},{"key":"10.1016\/j.rmed.2020.105904_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1843.2004.00573.x","article-title":"Effect of low-dose theophylline on airway inflammation in COPD","volume":"9","author":"Kobayashi","year":"2004","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2020.105904_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1164\/ajrccm.164.2.2006043","article-title":"Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma","volume":"164","author":"Lim","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2020.105904_bib7","first-page":"261","article-title":"A meta-analysis on the efficacy of oral theophylline in patients with stable COPD","volume":"1","author":"Molfino","year":"2006","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2020.105904_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.arbres.2015.02.021","article-title":"Chronic use of theophylline and mortality in chronic obstructive pulmonary disease: a meta-analysis","volume":"52","author":"Horita","year":"2016","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.rmed.2020.105904_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mpmed.2016.02.015","article-title":"Drugs for airway disease","volume":"44","author":"Bonini","year":"2016","journal-title":"Medicine"},{"issue":"21","key":"10.1016\/j.rmed.2020.105904_bib10","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199605233342107","article-title":"Theophylline in asthma","volume":"334","author":"Weinberger","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2020.105904_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12890-017-0527-y","article-title":"Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective","volume":"17","author":"Kibirige","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.rmed.2020.105904_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13223-019-0329-2","article-title":"Availability and affordability of medicines and diagnostic tests recommended for management of asthma and chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review","volume":"15","author":"Kibirige","year":"2019","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.rmed.2020.105904_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pupt.2010.04.002","article-title":"Doxofylline: a \"novofylline\"","volume":"23","author":"Page","year":"2010","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2020.105904_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pupt.2011.10.007","article-title":"The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism","volume":"25","author":"van Mastbergen","year":"2012","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2020.105904_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jmr.2549","article-title":"Identifying the antiasthmatic target of doxofylline using immobilized \u03b22-adrenoceptor based high-performance affinity chromatography and site-directed molecular docking","volume":"29","author":"Zhang","year":"2016","journal-title":"J. Mol. Recogn."},{"key":"10.1016\/j.rmed.2020.105904_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pupt.2014.01.001","article-title":"Doxofylline, a novofylline inhibits lung inflammation induced by lipopolysacharide in the mouse","volume":"27","author":"Riffo-Vasquez","year":"2014","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2020.105904_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2019.101851","article-title":"Comparison of anti-inflammatory mechanisms between doxofylline and theophylline in human monocytes","volume":"59","author":"Talmon","year":"2019","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2020.105904_bib18","first-page":"15","article-title":"Effects of oral doxofylline on inflammatory changes and altered cell proliferation in chronic obstructive bronchitis","volume":"4","author":"Cogo","year":"2000","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.rmed.2020.105904_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2017.10.008","article-title":"Steroid sparing effects of doxofylline","volume":"48","author":"Riffo-Vasquez","year":"2016","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2020.105904_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/PL00005027","article-title":"Convulsant effects of some xanthine derivatives in genetically epilepsy-prone rats","volume":"356","author":"De Sarro","year":"1997","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.rmed.2020.105904_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40360-017-0179-9","article-title":"Methylxanthines induce structural and functional alterations of the cardiac system in zebrafish embryos","volume":"18","author":"Basnet","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.rmed.2020.105904_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.1990.tb00512.x","article-title":"The effect of intravenous doxofylline or aminophylline on gastric secretion in duodenal ulcer patients","volume":"4","author":"Lazzaroni","year":"1990","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2020.105904_bib23","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.2147\/COPD.S150887","article-title":"Doxofylline is not just another theophylline!","volume":"12","author":"Matera","year":"2017","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2020.105904_bib24","first-page":"397","article-title":"Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial","volume":"9","author":"Melillo","year":"1989","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"10.1016\/j.rmed.2020.105904_bib25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1378\/chest.96.4.772","article-title":"Doxofylline and respiratory mechanics. Short-term effects in mechanically ventilated patients with airflow obstruction and respiratory failure","volume":"96","author":"Poggi","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2020.105904_bib26","first-page":"107","article-title":"Oral doxophylline in patients with chronic obstructive pulmonary disease","volume":"35","author":"Villani","year":"1997","journal-title":"Int. J. Clin. Pharm. Ther."},{"key":"10.1016\/j.rmed.2020.105904_bib27","first-page":"791","article-title":"Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial","volume":"106","author":"Santra","year":"2008","journal-title":"J. Indian Med. Assoc."},{"key":"10.1016\/j.rmed.2020.105904_bib28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s11596-011-0570-5","article-title":"Comparative study on the efficacy of tiotropium bromide inhalation and oral doxofylline treatment of moderate to severe stable chronic obstructive pulmonary disease","volume":"31","author":"Wang","year":"2011","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.rmed.2020.105904_bib29","first-page":"1681","article-title":"Doxofylline and theophylline: a comparative clinical study","volume":"6","author":"Akram","year":"2012","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.rmed.2020.105904_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2018.04.010","article-title":"Impact of doxofylline in COPD: a pairwise meta-analysis","volume":"51","author":"Cazzola","year":"2018","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2020.105904_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1467-8721.ep10768783","article-title":"Statistical power analysis","volume":"1","author":"Cohen","year":"1992","journal-title":"Curr. Dir. Psychol. Sci."},{"key":"10.1016\/j.rmed.2020.105904_bib32","author":"Higgins"},{"key":"10.1016\/j.rmed.2020.105904_bib33","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0010-2018","article-title":"Efficacy and safety profile of xanthines in COPD: a network meta-analysis","volume":"27","author":"Cazzola","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2020.105904_bib34","first-page":"CR297","article-title":"Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial","volume":"8","author":"Goldstein","year":"2002","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.rmed.2020.105904_bib35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/0022-3859.70937","article-title":"A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting \u03b22 agonist in the treatment of moderate-to-severe persistent asthma","volume":"56","author":"Patel","year":"2010","journal-title":"J. Postgrad. Med."},{"issue":"4","key":"10.1016\/j.rmed.2020.105904_bib36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.clinthera.2014.02.006","article-title":"Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline, and tiotropium with budesonide: a randomized controlled study","volume":"36","author":"Rajanandh","year":"2014","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.rmed.2020.105904_bib37","first-page":"FC05","article-title":"To study the efficacy and safety of doxophylline and theophylline in bronchial asthma","volume":"9","author":"Margay","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.rmed.2020.105904_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pupt.2018.09.007","article-title":"Impact of doxofylline compared to theophylline in asthma: a pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2)","volume":"53","author":"Calzetta","year":"2018","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2020.105904_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40248-019-0189-0","article-title":"Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis","volume":"14","author":"Rogliani","year":"2019","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.rmed.2020.105904_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14737167.2017.1301815","article-title":"Treatment plan comparison in acute and chronic respiratory tract diseases: an observational study of doxophylline vs. theophylline","volume":"17","author":"Mennini","year":"2017","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.rmed.2020.105904_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2014.5559","article-title":"How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature","volume":"312","author":"Murad","year":"2014","journal-title":"J. Am. Med. Assoc."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120300445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120300445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:56:56Z","timestamp":1760615816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120300445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":41,"alternative-id":["S0954611120300445"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.105904","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of doxofylline in asthma and COPD","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.105904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105904"}}